FOXP3 and non-small cell lung carcinoma: Jiae Koh et al. found that high frequencies of circulating Treg cells were correlated with a high response rate, longer PFS and OS, and higher levels of FOXP3+ Treg cells could predict a favorable response to anti-PD-1 immunotherapy in patients with advanced NSCLC [57].